指南与共识耳科与耳神经

临床实践指南:良性阵发性位置性眩晕(更新版)

Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update).
指南 / 共识 · Otolaryngol Head Neck Surg · 2017-01-01

美国耳鼻咽喉头颈外科学会基金会更新2008年良性阵发性位置性眩晕指南,基于2项临床实践指南、20项系统综述和27项随机对照试验的新证据,强调患者教育与共享决策,提出诊断、手法复位及避免前庭抑制药物和影像学检查等推荐。

要点

  • 后半规管BPPV:Dix-Hallpike试验诱发扭转性上跳性眼震即可诊断,推荐手法复位治疗。
  • 后半规管BPPV复位后不推荐体位限制;不推荐常规使用前庭抑制药物。
  • 符合诊断标准且无额外指征者,不推荐影像学或前庭功能检查。

核心结论

  • 指南旨在提高BPPV诊断准确性和效率,减少前庭抑制药物及影像学等辅助检查的不当使用,增加适当复位手法的使用。

研究设计与样本

  • 美国耳鼻咽喉头颈外科学会基金会更新2008年指南,纳入2项临床实践指南、20项系统综述和27项随机对照试验的新证据,更新组新增消费者代表。
  • 目标人群为年龄≥18岁、疑似或潜在诊断为BPPV的患者,适用于所有可能诊断和管理BPPV的临床场景。

主要发现

  • 主要结局为BPPV相关症状的缓解;次要结局包括提高诊断准确率、更高效恢复正常活动和工作、减少不当药物和不必要检查、降低复发及不良事件。
  • 其他结局包括降低诊疗费用、减少不必要的复诊及最大化健康相关生活质量。

关键数值与推荐

  • 强推荐:当Dix-Hallpike手法(患者从直立位至仰卧位,头转向一侧45°、颈伸展20°、患耳向下)诱发扭转性上跳性眼震时,诊断后半规管BPPV。
  • 强推荐:对后半规管BPPV患者行手法复位治疗,或转诊至能行此治疗的临床医生。
  • 强推荐反对:后半规管BPPV手法复位后行体位限制。
  • 推荐:若病史符合BPPV而Dix-Hallpike试验出现水平眼震或无眼震,行仰卧滚转试验评估外半规管BPPV,或转诊。
  • 推荐:将BPPV与其他失衡、头晕和眩晕原因相鉴别,或转诊。

临床怎么用

  • 临床医生应按照指南推荐诊断后半规管BPPV并行手法复位,或转诊至能行此治疗的医生。
  • 避免对符合诊断标准且无额外指征的BPPV患者行影像学或前庭功能检查,避免常规使用前庭抑制药物。
  • 对BPPV患者评估影响管理的因素,1个月内重新评估,并教育安全、复发和随访。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective This update of a 2008 guideline from the American Academy of Otolaryngology-Head and Neck Surgery Foundation provides evidence-based recommendations to benign paroxysmal positional vertigo (BPPV), defined as a disorder of the inner ear characterized by repeated episodes of positional vertigo. Changes from the prior guideline include a consumer advocate added to the update group; new evidence from 2 clinical practice guidelines, 20 systematic reviews, and 27 randomized controlled trials; enhanced emphasis on patient education and shared decision making; a new algorithm to clarify action statement relationships; and new and expanded recommendations for the diagnosis and management of BPPV. Purpose The primary purposes of this guideline are to improve the quality of care and outcomes for BPPV by improving the accurate and efficient diagnosis of BPPV, reducing the inappropriate use of vestibular suppressant medications, decreasing the inappropriate use of ancillary testing such as radiographic imaging, and increasing the use of appropriate therapeutic repositioning maneuvers. The guideline is intended for all clinicians who are likely to diagnose and manage patients with BPPV, and it applies to any setting in which BPPV would be identified, monitored, or managed. The target patient for the guideline is aged ≥18 years with a suspected or potential diagnosis of BPPV. The primary outcome considered in this guideline is the resolution of the symptoms associated with BPPV. Secondary outcomes considered include an increased rate of accurate diagnoses of BPPV, a more efficient return to regular activities and work, decreased use of inappropriate medications and unnecessary diagnostic tests, reduction in recurrence of BPPV, and reduction in adverse events associated with undiagnosed or untreated BPPV. Other outcomes considered include minimizing costs in the diagnosis and treatment of BPPV, minimizing potentially unnecessary return physician visits, and maximizing the health-related quality of life of individuals afflicted with BPPV. Action Statements The update group made strong recommendations that clinicians should (1) diagnose posterior semicircular canal BPPV when vertigo associated with torsional, upbeating nystagmus is provoked by the Dix-Hallpike maneuver, performed by bringing the patient from an upright to supine position with the head turned 45° to one side and neck extended 20° with the affected ear down, and (2) treat, or refer to a clinician who can treat, patients with posterior canal BPPV with a canalith repositioning procedure. The update group made a strong recommendation against postprocedural postural restrictions after canalith repositioning procedure for posterior canal BPPV. The update group made recommendations that the clinician should (1) perform, or refer to a clinician who can perform, a supine roll test to assess for lateral semicircular canal BPPV if the patient has a history compatible with BPPV and the Dix-Hallpike test exhibits horizontal or no nystagmus; (2) differentiate, or refer to a clinician who can differentiate, BPPV from other causes of imbalance, dizziness, and vertigo; (3) assess patients with BPPV for factors that modify management, including impaired mobility or balance, central nervous system disorders, a lack of home support, and/or increased risk for falling; (4) reassess patients within 1 month after an initial period of observation or treatment to document resolution or persistence of symptoms; (5) evaluate, or refer to a clinician who can evaluate, patients with persistent symptoms for unresolved BPPV and/or underlying peripheral vestibular or central nervous system disorders; and (6) educate patients regarding the impact of BPPV on their safety, the potential for disease recurrence, and the importance of follow-up. The update group made recommendations against (1) radiographic imaging for a patient who meets diagnostic criteria for BPPV in the absence of additional signs and/or symptoms inconsistent with BPPV that warrant imaging, (2) vestibular testing for a patient who meets diagnostic criteria for BPPV in the absence of additional vestibular signs and/or symptoms inconsistent with BPPV that warrant testing, and (3) routinely treating BPPV with vestibular suppressant medications such as antihistamines and/or benzodiazepines. The guideline update group provided the options that clinicians may offer (1) observation with follow-up as initial management for patients with BPPV and (2) vestibular rehabilitation, either self-administered or with a clinician, in the treatment of BPPV.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Bhattacharyya N, Gubbels SP, Schwartz SR, et al. Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update). Otolaryngol Head Neck Surg. 2017. PMID: 28248609. doi:10.1177/0194599816689667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。